Menu
GeneBe

PDE1A

phosphodiesterase 1A, the group of Phosphodiesterases

Basic information

Region (hg38): 2:182139967-182523359

Links

ENSG00000115252OMIM:171890HGNC:8774Uniprot:P54750AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the PDE1A gene.

  • not provided (30 variants)
  • Inborn genetic diseases (14 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the PDE1A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
13
clinvar
1
clinvar
14
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
2
2
non coding
28
clinvar
28
Total 0 0 13 1 28

Variants in PDE1A

This is a list of pathogenic ClinVar variants found in the PDE1A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
2-182147146-G-A not specified Uncertain significance (Sep 21, 2023)3210642
2-182168051-T-C Benign (May 14, 2021)1238921
2-182168293-GA-G Benign (May 14, 2021)1268286
2-182168475-A-G Benign (May 14, 2021)1258905
2-182185900-G-T not specified Uncertain significance (Nov 06, 2023)3210641
2-182185955-T-G not specified Uncertain significance (Jun 29, 2023)2607382
2-182185973-C-T not specified Uncertain significance (Jan 03, 2024)3210640
2-182186054-T-C not specified Likely benign (May 26, 2023)2552006
2-182186068-A-G not specified Uncertain significance (Jun 28, 2022)2354342
2-182186075-T-C not specified Uncertain significance (Feb 10, 2022)2213579
2-182186236-C-G Benign (May 14, 2021)1267048
2-182186483-G-A not specified Uncertain significance (Mar 27, 2023)2570465
2-182186520-G-A not specified Uncertain significance (Feb 22, 2023)2487613
2-182186572-T-C not specified Uncertain significance (Nov 22, 2023)3210638
2-182186694-A-G Benign (May 13, 2021)1239898
2-182186722-T-C Benign (May 14, 2021)1253451
2-182188917-T-A Benign (May 14, 2021)1289577
2-182188931-C-G Benign (May 13, 2021)1291679
2-182201650-C-CA Benign (May 13, 2021)1233623
2-182201650-C-CAA Benign (May 15, 2021)1231444
2-182201650-C-CAAA Benign (May 13, 2021)1238438
2-182201650-C-CAAAAA Benign (May 22, 2021)1284004
2-182201650-C-CAAAAAA Benign (May 31, 2021)1265372
2-182201664-C-A Benign (May 13, 2021)1226653
2-182201710-T-C not specified Uncertain significance (Jun 22, 2021)2234382

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
PDE1Aprotein_codingprotein_codingENST00000435564 14383157
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.01350.9861257251171257430.0000716
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.9672462930.8410.00001503587
Missense in Polyphen91130.40.697851619
Synonymous-0.3751061011.050.00000521996
Loss of Function3.53929.80.3020.00000148376

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.00002890.0000289
Ashkenazi Jewish0.000.00
East Asian0.0001720.000163
Finnish0.00004640.0000462
European (Non-Finnish)0.00006260.0000615
Middle Eastern0.0001720.000163
South Asian0.0001970.000163
Other0.0001670.000163

dbNSFP

Source: dbNSFP

Function
FUNCTION: Cyclic nucleotide phosphodiesterase with a dual- specificity for the second messengers cAMP and cGMP, which are key regulators of many important physiological processes. Has a higher affinity for cGMP than for cAMP.;
Pathway
Calcium signaling pathway - Homo sapiens (human);Renin secretion - Homo sapiens (human);Purine metabolism - Homo sapiens (human);Taste transduction - Homo sapiens (human);Olfactory transduction - Homo sapiens (human);Morphine addiction - Homo sapiens (human);G Protein Signaling Pathways;Phosphodiesterases in neuronal function;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Calmodulin induced events;CaM pathway;Cam-PDE 1 activation;Purine nucleotides nucleosides metabolism;Hemostasis;DAG and IP3 signaling;Ca-dependent events;PLC beta mediated events;G-protein mediated events;Opioid Signalling;G alpha (i) signalling events;cGMP effects;Nitric oxide stimulates guanylate cyclase;Platelet homeostasis;GPCR downstream signalling;Intracellular signaling by second messengers (Consensus)

Recessive Scores

pRec
0.201

Intolerance Scores

loftool
0.376
rvis_EVS
-0.73
rvis_percentile_EVS
14.02

Haploinsufficiency Scores

pHI
0.225
hipred
Y
hipred_score
0.546
ghis
0.611

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
gene_indispensability_pred
E
gene_indispensability_score
0.561

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Pde1a
Phenotype

Zebrafish Information Network

Gene name
pde1a
Affected structure
pronephric tubule
Phenotype tag
abnormal
Phenotype quality
dilated

Gene ontology

Biological process
G protein-coupled receptor signaling pathway;regulation of smooth muscle cell apoptotic process;cGMP catabolic process;regulation of smooth muscle cell proliferation
Cellular component
nucleus;cytosol;neuronal cell body
Molecular function
3',5'-cyclic-AMP phosphodiesterase activity;calmodulin-dependent cyclic-nucleotide phosphodiesterase activity;calmodulin binding;metal ion binding;3',5'-cyclic-GMP phosphodiesterase activity;calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity